期刊文献+

转化生长因子β在肿瘤微环境中的作用及其靶向药物研究进展

The role of transforming growth factor-βin tumor microenvironment and research progress of its targeting drugs
原文传递
导出
摘要 转化生长因子β (transforming growth factor-β,TGF-β)是一种多效性细胞因子,属于调节细胞生长和分化的TGF-β超家族。在肿瘤发展的后期,自分泌和旁分泌的TGF-β可能通过诱导上皮-间质转化、促进肿瘤血管生成、调节免疫抑制来调控肿瘤的转移和复发。因此,TGF-β被认为是晚期肿瘤生长、进展和转移潜能的重要因素。中和或阻断TGF-β是一种干预和干扰肿瘤生长关键启动子的独特方法,可能会提供一个新的治疗机会。此文就TGF-β的结构、功能及其在肿瘤微环境中的作用机制进行综述,并列举了一些在研的靶向TGF-β药物,旨在为抗肿瘤药物的开发和临床应用提供参考。 Transforming growth factor-β(TGF-β)is a pleiotropic cytokine which belongs to the TGF-βsuperfamily that regulates cell growth and differentiation.In the later stages of tumor development,TGF-βmay regulate tumor metastasis and recurrence by inducing epithelial-mesenchymal transition,promoting tumor angiogenesis and regulating immunosuppression through autocrine and paracrine effects.Therefore,TGF-βhas been implicated as an important factor in the growth,progression,and metastatic potential of advanced cancers.Neutralizing or blocking TGF-βrepresents a unique method of intervening and disrupting a key promoter of tumor growth and may provide a new therapeutic opportunity.This review discusses the structure,function and mechanism of TGF-βin tumor microenvironment,and lists some drugs targeting TGF-β,aiming to provide reference for the development and clinical application of anti-tumor drugs.
作者 马钧 Ma Jun(No.1 Research Laboratory,Shanghai Institute of Biological Products Co.,Ltd.,Shanghai 200051,China)
出处 《国际生物制品学杂志》 CAS 2023年第2期103-108,共6页 International Journal of Biologicals
关键词 转化生长因子Β 肿瘤微环境 肿瘤发生发展 肿瘤免疫治疗 靶向药物 Transforming growth factor beta Tumor microenvironment Tumorigenesis development Tumor immunotherapy,targeted drugs
  • 相关文献

参考文献8

二级参考文献42

  • 1陈红艳,杨新波,王建华,卢立军,曹文斌,黄正明.四氧嘧啶糖尿病小鼠模型的制备及影响因素[J].军事医学科学院院刊,2005,29(6):535-537. 被引量:21
  • 2范海涛,白利群,陈秀玲,曹颖慧,刘禄成.人膀胱癌中TGF-β1及其信号转导分子的表达及意义[J].肿瘤,2006,26(2):181-183. 被引量:5
  • 3唐正严,杨罗艳,张永琎,彭克亮,齐琳.Smad4与TGF-β_1在膀胱移行细胞癌中的表达及临床意义[J].中南大学学报(医学版),2006,31(3):363-366. 被引量:3
  • 4左杰,史启铎,孙光.TGF-β1在膀胱移行细胞癌中的表达及其对血管生成的调节作用[J].透析与人工器官,2007,18(2):19-21. 被引量:4
  • 5Beecken WD,Engl T,Jonas D,et al.Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy.Int J Mol Med,2009;23(2):261-266.
  • 6Yin JJ,Selander K,Chirgwin JM,et al.TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.J Clin Invest,1999,103(2):197-206.
  • 7Schmid SA,Gaumann A,Wondrak M,et al.Lactate adversely affects the in vitro formation of endothelial cell tubular structures through the action of TGF-betal.Exp Cell Res,2007,313(12):2531-2549.
  • 8Robson CN,Gnanapragasam V,Byrne RL,et al.Transforming growth faetor-betal up-regulates p15,p21 and p27 and blocks cell cycling in G1 in human prostate epithelium.J Endocrinol,1999;160(2):257-266.
  • 9Eder IE,Stenzl A,Hobiseh A,et al.Expression of transforming growth factors beta1,beta2 and beta3 in human bladder carcinomas.Br J Cancer,1997,75(12):1753-1760.
  • 10Xiong B,Gong LL,Zhang F,etal.TGF beta1 expression and angiogenesis in colorectal cancer tissue.World J Gastroenterol,2002;8(3):496-498.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部